Why Cigna Deal With Humana Made Little Sense To Begin With
The Cigna Group confirmed “it is not pursuing a combination with Humana.”
Cigna rallies after Humana mega-merger called off
US health insurer Cigna has made the appropriate decision to ditch plans to merge with rival Humana (NYSE:HUM), if today's market reaction is anything to go by. Rumours of the merger, which would have created a $140 billion insurance behemoth, began circulating last December, but doubts over the deal quickly followed.
Cigna says it will not pursue combination with Humana
Health insurer Cigna Group said on Monday it is not pursuing a combination with peer Humana.
Cigna's Impressive Q3: 4 Compelling Reasons To Buy Now
The Cigna Group's Q3 2024 results showed once again strong revenue and earnings growth. Yet, CI shares are down almost 20% from their 52-week-high. In this article, I will discuss the reasons for the once again favorable valuation of CI stock and explain why I seized what I believe to be a compelling opportunity. I will also give my opinion on the renewed speculation about a possible merger with Humana and explain why the concerns are likely unfounded.
Here's Why Cigna (CI) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Cigna (CI) Reports Q3 Earnings: What Key Metrics Have to Say
The headline numbers for Cigna (CI) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
The Cigna Group (CI) Q3 2024 Earnings Call Transcript
The Cigna Group (NYSE:CI ) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ET Company Participants Ralph Giacobbe - Senior Vice President of Investor Relations David Cordani - Chairman and Chief Executive Officer Brian Evanko - Chief Financial Officer and President and Chief Executive Officer, Cigna Healthcare Eric Palmer - President and Chief Executive Officer, Evernorth Health Services Conference Call Participants AJ Rice - UBS Justin Lake - Wolfe Research Ryan Langston - TD Cowen Lisa Gill - JPMorgan Andrew Mok - Barclays Erin Wright - Morgan Stanley Scott Fidel - Stephens Adam Ron - Bank of America George Hill - Deutsche Bank Josh Raskin - Nephron Research Lance Wilkes - Bernstein Michael Ha - Baird Operator Ladies and gentlemen, thank you for standing by for the Cigna Group's Third Quarter 2024 Results Review. At this time all callers are in a listen-only mode.
Cigna Q3 Earnings Beat on Client Wins & Specialty Business Strength
CI's strong third-quarter results benefit from a strong Evernorth Health Services segment. Higher expenses partially offset the positives.
Cigna (CI) Surpasses Q3 Earnings and Revenue Estimates
Cigna (CI) came out with quarterly earnings of $7.51 per share, beating the Zacks Consensus Estimate of $7.22 per share. This compares to earnings of $6.77 per share a year ago.
Cigna tops quarterly profit estimates on strength in pharmacy benefit management unit
Cigna beat Wall Street estimates for third-quarter profit on Thursday, as its unit that runs the pharmacy benefit management business added new clients and saw strong demand for close copies of a blockbuster arthritis drug.
Cigna Turns $739 Million Profit Despite $1 Billion Loss On VillageMD
The Cigna Group reported a $739 million third quarter profit despite a $1 billion loss on its investment in clinic operator VillageMD.
